help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hosseini, S. H.
Right arrow Articles by Lewis, W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hosseini, S. H.
Right arrow Articles by Lewis, W.
(American Journal of Pathology. 2007;170:865-874.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.060655

Targeted Transgenic Overexpression of Mitochondrial Thymidine Kinase (TK2) Alters Mitochondrial DNA (mtDNA) and Mitochondrial Polypeptide Abundance

Transgenic TK2, mtDNA, and Antiretrovirals

Seyed H. Hosseini*, James J. Kohler*, Chad P. Haase*, Nina Tioleco*, Tami Stuart*, Erin Keebaugh*, Tomika Ludaway*, Rodney Russ*, Elgin Green*, Robert Long{dagger}, Liya Wang{ddagger}, Staffan Eriksson{ddagger} and William Lewis*

From the Departments of Pathology* and Radiology,{dagger} Emory University, Atlanta, Georgia; and the Department of Molecular Biosciences,{ddagger} Swedish University of Agricultural Sciences, Uppsala, Sweden

Mitochondrial toxicity limits nucleoside reverse transcriptase inhibitors (NRTIs) for acquired immune deficiency syndrome. NRTI triphosphates, the active moieties, inhibit human immunodeficiency virus reverse transcriptase and eukaryotic mitochondrial DNA polymerase pol-{gamma}. NRTI phosphorylation seems to correlate with mitochondrial toxicity, but experimental evidence is lacking. Transgenic mice (TGs) with cardiac overexpression of thymidine kinase isoforms (mitochondrial TK2 and cytoplasmic TK1) were used to study NRTI mitochondrial toxicity. Echocardiography and nuclear magnetic resonance imaging defined cardiac performance and structure. TK gene copy and enzyme activity, mitochondrial (mt) DNA and polypeptide abundance, succinate dehydrogenase and cytochrome oxidase histochemistry, and electron microscopy correlated with transgenesis, mitochondrial structure, and biogenesis. Antiretroviral combinations simulated therapy. Untreated hTK1 or TK2 TGs exhibited normal left ventricle mass. In TK2 TGs, cardiac TK2 gene copy doubled, activity increased 300-fold, and mtDNA abundance doubled. Abundance of the 17-kd subunit of complex I, succinate dehydrogenase histochemical activity, and cristae density increased. NRTIs increased left ventricle mass 20% in TK2 TGs. TK activity increased 3 logs in hTK1 TGs, but no cardiac phenotype resulted. NRTIs abrogated functional effects of transgenically increased TK2 activity but had no effect on TK2 mtDNA abundance. Thus, NRTI mitochondrial phosphorylation by TK2 is integral to clinical NRTI mitochondrial toxicity.





This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Solaroli, X. Zheng, M. Johansson, J. Balzarini, and A. Karlsson
Mitochondrial Expression of the Drosophila melanogaster Multisubstrate Deoxyribonucleoside Kinase
Mol. Pharmacol., December 1, 2007; 72(6): 1593 - 1598.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.